UNSPSC 85541921: Supplement cisterna chyli with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement cisterna chyli with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07UL4KZ

UNSPSC 85541921 Supplement cisterna chyli with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not align with the scope of recent state and local procurement activity posted under this code. The recent opportunities—including independent medical evaluation services for pension-board disability determinations, surgical benefit program carve-outs, occupational medical surveillance, emergency medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing—reflect general healthcare administration, occupational health, and clinical staffing procurement. None of these solicitations involve the specific surgical procedure named in the code (cisternal chyli supplementation via percutaneous endoscopy), and the mismatch suggests either a data-tagging error or minimal recent activity directly aligned with this narrow procedural commodity.

The issuing bodies span state departments (Washington State Department of Transportation), county health systems and probation departments (Harris County, Collier County, Santa Clara County), and city pension and benefits offices (Phoenix, Long Beach). Geographic activity appears concentrated in Arizona, California, Florida, and Washington. Without recent solicitations that actually procure the procedure or related surgical supplies and services named in this Commodity code, the practical market signal is one of inactivity. Firms pursuing this code should verify whether state and local procurement offices are actively buying related implants, instruments, or clinical services before investing in business development; the posted records suggest limited or no alignment between the code taxonomy and actual recent demand.